bcl-2 Expression on Prostate Cancer and its Relationship to Cell Cycle and Prognosis

International Journal of Urology

Volumn 3, Issue 2, 1996, Pages 113-117

  Matsushima, Hisashi ^a   Hosaka, Yoshio ^b   Suzuki, Makoto ^a   Mizutani, Takashi ^a   Ishizuka, Hideshi ^a   Kawabe, Kazuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

bcl 2; Cell cycle; Flow cytometry; Immunohistochemistry; Prognosis; Prostate cancer

Indexed keywords

DNA; ONCOPROTEIN; PROTEIN BCL 2;

ADENOCARCINOMA; AGED; ARTICLE; BIOSYNTHESIS; CELL CYCLE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; RETROSPECTIVE STUDY; TISSUE DISTRIBUTION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CELL CYCLE; DNA; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; TISSUE DISTRIBUTION;

EID: 0030099106     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1996.tb00494.x     Document Type: Article

References (23)

1. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce C. The t(14;18) chromosome translocation involved in B-cell neoplasms results from mistakes in VDJ joining. Science 1985;229:1390-1393.
2. Cleary M, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985;82:7439-7443.
3. McDonnell T, Deane N, Platt F, Nunez G, Jaeger U, McKearn J, Korsmeyer S. bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989;57:79-88.
4. Deng G, Podack E. Suppression of apoptosis in cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci USA 1993;90: 2189-2193.
5. Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer S. bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991;88:6961-6965.
6. Bhargava V, Kell D, van-de-Rijn M, Warnke R. Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 1994; 145:535-540.
7. Joensuu H, Pylkkanen L, Toikkanen S. Bcl-2 protein expression and long term survival in breast cancer. Am J Pathol 1994;145:1191-1198.
8. McDonnell T, Troncoso P, Brisbay S, Logothetis C, Chung L, Hsieh J, Tu S, Campbell M. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgenindependent prostate cancer. Cancer Res 1992;52:6940-6944.
9. Pilotti S, Collini P, Rilke F, Cattoretti C, Del-Bo R, Pierotti M. Bcl-2 protein expression in carcinoma originating from the follicular epithelium of the thyroid gland. J Pathol 1994;172:337-342.
10. Segal N, Cohen R, Haffejee Z, Savage N. Bcl-2 protooncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell. Arch Pathol Lab Med 1994;118:616-618.
11. Dermer G. Basal cell proliferation in benign prostatic hyperplasia. Cancer 1978;41:1857-1862.
12. Kyprianou N, English H, Isaacs J. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 1990;50: 3748-3753.
13. Colombel M, Symmans F, Gil S, O'Toole K, Chopin D, Benson M, Olsson C, Korsmeyer S, Buttyan R. Detection of the apoptosis-suppressing oncoprotein Bcl-2 in hormone refractory human prostate cancers. Am J Pathol 1993;143:390-400.
14. Shi S, Key M, Ralra K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-748.
15. Pezzella F, Tse A, Cordell J, Pulford R, Gatter R, Mason D. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990;137:225-232.
16. Giorno R. A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol 1984;2:161.
17. Hedley DW, Friedlander ML, Taylor IW. Method for analysis of cellular DNA content of paraffin-embedded pathological materials using flow cytometry. J Histochem Cytochem 1983;31:1333-1335.
18. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-327.
19. Fried J, Perz A, Clarkson B. Flow cytometric analysis of cell cycle distribution using propidium iodide. Properties of the method and mathematical analysis of the data. J Cell Biol 1982;71:172-181.
20. Hiddemann W, Schumann J, Andreef M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, Sandberg AA. Convention on nomenclature for DNA cytometry. Cancer Genet Cytogenet 1984;13:181-183.
21. Deitch AD, de Vere White RW. Flow cytometry as a predictive modality in prostate cancer. Hum Pathol 1992;23:352-359.
22. Voges GE, Eigner EB, Ross W, Sussman H, Stockle M, Hreira FS, Stamey TA. Pathologic parameters and flow cytometric ploidy analysis in predicting recurrence in carcinoma of the prostate. Eur Urol 1993;24:132-139.
23. Piris M, Pezzella F, Martinez-Montero J, Orradre J, Villuendas R, Sanchez-Beato M, Cuena R, Cruz M, Martinez B. p53 and bcl-2 expression in highgrade B cell lymphomas: correlation with survival time. Br J Cancer 1994;69:337-341.